Fatty Liver

A condition where fat accumulates in the liver, often driven by fructose metabolism—can lead to inflammation and insulin resistance.

A Silent Epidemic Begins in the Liver

Fatty liver isn’t just about eating fat—it’s often about how your body handles sugar, especially fructose.

Fructose is uniquely lipogenic, meaning it turns into fat more efficiently than other sugars—directly in the liver. This fat buildup can occur even in lean individuals, especially when endogenous fructose is produced under stress or high-carb intake, silently progressing into non-alcoholic fatty liver disease (NAFLD).

SugarShield is designed to support metabolic health at the root. By helping manage the effects of fructose metabolism, it aids the body in maintaining healthy liver fat levels and reducing the cellular stress that leads to long-term dysfunction.

Explore SugarShield

What is Fatty Liver?

Fatty liver is a buildup of fat in liver cells, often without symptoms at first. Over time, it can progress to inflammation (NASH), fibrosis, cirrhosis, and liver failure.

Causes

The most common non-alcoholic cause is fructose overconsumption, which drives liver fat synthesis via de novo lipogenesis.

The Fructose Pathway

Fructose is taken up by the liver and rapidly converted into fat, depleting energy and generating uric acid. Even without sugar, endogenous fructose production can continue the cycle.

Consequences

Fatty liver contributes to:
- Insulin resistance
- Inflammation
- Higher cholesterol
- Increased disease risk

LIV3's Role

By targeting fructose metabolism directly—with fructokinase inhibitors and uric acid reducers—we believe fatty liver can be reversed at the metabolic source, not just masked through calorie reduction."

Related Articles

Luteolin: The Anti-Sugar Nutrient You’ve Never Heard Of (But Need to Know About)

Luteolin: The Anti-Sugar Nutrient You’ve Never Heard Of (But Need to Know About)

Luteolin is a rare plant flavonoid shown to naturally quiet the fructose pathway—the same metabolic switch targeted by pharmaceutical fructokinase inhibitors. By protecting cellular energy and lowering uric acid and inflammation, it helps restore the stable, high-efficiency metabolism that modern diets have lost.

Huntington’s Disease Breakthrough: Gene Therapy AMT-130 and the Energy Failure Model

Huntington’s Disease Breakthrough: Gene Therapy AMT-130 and the Energy Failure Model

A new gene therapy has slowed Huntington’s disease progression for the first time — a historic breakthrough. Seen through the energy failure model, it also highlights how metabolic stress like fructose stacks on top of genetic insults, and why research on luteolin is showing promise across multiple neurodegenerative conditions.

Tylenol, Autism Risk, and Fragile Energy: What Does the Science Really Say?

Tylenol, Autism Risk, and Fragile Energy: What Does the Science Really Say?

The Tylenol–autism debate shows how easily developing brains can be tipped when cellular energy is fragile. Our research suggests a bigger story: the Fructose Model — a framework showing how daily sugar exposure creates the same low-energy state across the whole body.

The Fructose–Insulin Connection: What Doctors Aren’t Telling You About Weight Loss Resistance

The Fructose–Insulin Connection: What Doctors Aren’t Telling You About Weight Loss Resistance

Doctors often blame carbs in general, but that's only part of the story. To really answer what causes insulin resistance, we need to look at fructose. If the engine is the problem, pressing harder on the gas pedal won't help. Instead, the solution is to improve how the cell handles fuel and gradually rebuild insulin sensitivity.

My Cart
0